Anthony P. Zook - 01 Apr 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: NEO
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 16:38:47 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Ali Olivo, Attorney-in-Fact

Key filing fact

Anthony P. Zook filed Form 4 for NEOGENOMICS INC (NEO) on 03 Apr 2026.

Key facts

This page summarizes Anthony P. Zook's Form 4 filing for NEOGENOMICS INC (NEO).
3 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 16:38.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001582393 Primary reporting owner

Zook Anthony P.

Relationship: Chief Executive Officer, Director
Address: 9490 NEOGENOMICS WAY, FORT MYERS
Signature: /s/ Ali Olivo, Attorney-in-Fact
Signature date: 03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value
Shares: +140,498
Change %: +369%
Price: $0.000000^*
Shares after: 178,564
Date: 01 Apr 2026
Ownership: Direct

NEO transaction

Common Stock

Tax liability

Transaction value
Shares: -45,453
Change %: -25%
Price: $0.000000^*
Shares after: 133,111
Date: 01 Apr 2026
Ownership: Direct

NEO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 18,900
Date: 01 Apr 2026
Ownership: Amended and Restated Anthony P. Zook Living Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -140,498
Change %: -33%
Price: $0.000000^*
Shares after: 280,998
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 140,498
Exercise price: $0.000000
Footnotes: F1, F2

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,353
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,353
Exercise price: $14.82

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,672
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,672
Exercise price: $13.71

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 729,927
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 729,927
Exercise price: $10.44
Footnotes: F3, F4

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 675,676
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 675,676
Exercise price: $10.81
Footnotes: F5, F6

NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 406,918
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 406,918
Exercise price: $0.000000
Footnotes: F2, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F2

Once vested, the shares of common stock are not subject to expiration.

Footnote F3

This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.

Footnote F4

On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.

Footnote F5

This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.

Footnote F6

On March 1, 2026, Mr. Zook was granted 675,676 stock options. The options vest ratably over the first three anniversary dates of the grant date.

Footnote F7

On March 1, 2026, Mr. Zook was granted 406,918 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.